StrataMGT for the Treatment of Vulvar Lichen Sclerosus
Conditions: Vulvar Lichen Sclerosus Interventions: Device: StrataMGT Sponsors: Center for Vulvovaginal Disorders; Stratpharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus
Conditions: Lichen Sclerosus Interventions: Device: Treatment with Monalisa Glide Laser; Drug: Treatment with Clobetasol Sponsors: Kantonsspital Winterthur KSW Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)
Conditions: Vulvar Lichen Sclerosus Interventions: Drug: MC2-25 cream; Drug: MC2-25 vehicle Sponsors: MC2 Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique)
Conditions: Lichen Sclerosus of External Female Genital Organs Interventions: Procedure: Infiltration of triamcinolone acetonide (2mg/ml) through syringes and needles; Procedure: Infiltration of triamcinolone acetonide 40 mg/ml) through tattoo machines Sponsors: Clinica Dermatologica Arbache ltda Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome
Condition: Lichen Sclerosus Intervention: Sponsors: Region Jönköping County; FORSS, Forskningsrådet i Sydöstra Sverige; Futurum - Academy for health and care Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
Condition: Lichen Sclerosus Interventions: Drug: Ruxolitinib cream; Drug: Vehicle cream Sponsor: Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2022 Category: Research Source Type: clinical trials
